Patents by Inventor John De Jersey

John De Jersey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250313881
    Abstract: This invention relates to the use of clotting compositions containing prothrombin activators to produce high quality blood serum samples for pathology and other biological assays, and to contains containing such clotting compositions, and related methods of use.
    Type: Application
    Filed: January 6, 2025
    Publication date: October 9, 2025
    Inventors: Paul Masci, John De Jersey, Martin Lavin, Julie Phillips, Goce Dimeski
  • Patent number: 11103560
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: August 31, 2021
    Assignee: Q-SERA PTY LTD.
    Inventors: Paul Masci, Kong-Nan Zhao, Martin Lavin, John De Jersey, Goce Dimeski
  • Publication number: 20210000925
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Application
    Filed: August 4, 2020
    Publication date: January 7, 2021
    Inventors: Paul MASCI, Kong-Nan ZHAO, Martin LAVIN, John DE JERSEY, Goce DIMESKI
  • Patent number: 10786553
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: September 29, 2020
    Assignee: Q-SERA PTY LTD.
    Inventors: Paul Masci, Kong-Nan Zhao, Martin Lavin, John De Jersey, Goce Dimeski
  • Publication number: 20190390248
    Abstract: This invention relates to the use of clotting compositions containing prothrombin activators to produce high quality blood serum samples for pathology and other biological assays, and to containers containing such clotting compositions, and related methods of use.
    Type: Application
    Filed: July 5, 2019
    Publication date: December 26, 2019
    Inventors: Paul Masci, John De Jersey, Martin Lavin, Julie Phillips, Goce Dimeski
  • Patent number: 10385381
    Abstract: This invention relates to the use of clotting compositions containing prothrombin activators to produce high quality blood serum samples for pathology and other biological assays, and to containers containing such clotting compositions, and related methods of use.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: August 20, 2019
    Inventors: Paul Masci, John De Jersey, Martin Lavin, Julie Phillips, Goce Dimeski
  • Publication number: 20170304407
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Application
    Filed: October 23, 2015
    Publication date: October 26, 2017
    Inventors: Paul Masci, Kong-Nan Zhao, Martin Lavin, John De Jersey, Goce Dimeski
  • Patent number: 9200020
    Abstract: The invention relates to compounds which are useful as inhibitors of 6-oxopurine phosphoribosyltransferases such as hypoxanthine-guanine-(xanthine) phosphoribosyltransferase (HG(X)PRT).
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: December 1, 2015
    Assignees: THE UNIVERSITY OF QUEENSLAND, INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR, V.V.I.
    Inventors: John De Jersey, Luke William Guddat, Dana Hockova, Dianne Therese Keough
  • Publication number: 20150099722
    Abstract: The invention relates to compounds which are useful as inhibitors of 6-oxopurine phosphoribosyltransferases such as hypoxanthine-guanine-(xanthine) phosphoribosyltransferase (HG(X)PRT).
    Type: Application
    Filed: May 7, 2013
    Publication date: April 9, 2015
    Inventors: John De Jersey, Luke William Guddat, Dana Hockova, Dianne Therese Keough
  • Publication number: 20130273584
    Abstract: This invention relates to the use of clotting compositions containing prothrombin activators to produce high quality blood serum samples for pathology and other biological assays, and to containers containing such clotting compositions, and related methods of use.
    Type: Application
    Filed: September 20, 2011
    Publication date: October 17, 2013
    Applicant: THE UNIVERSITY OF QUEENSLAND
    Inventors: Paul Masci, John De Jersey, Martin Lavin, Julie Phillips
  • Publication number: 20110053851
    Abstract: This invention discloses the use of snake venom FV polypeptides in methods and compositions for preventing or reducing blood loss or bleeding during bleeding episodes.
    Type: Application
    Filed: December 18, 2008
    Publication date: March 3, 2011
    Applicants: THE UNIVERSITY OF QUEENSLAND, VENOMICS PTY LTD
    Inventors: Paul Pantaleone Masci, John De Jersey
  • Patent number: 7745192
    Abstract: The invention relates to snake venom protease polypeptides and nucleic acid sequences encoding same. This invention also relates to methods of making and using the snake venom proteases, e.g., to promote haemostasis and prevent blood loss such as during surgery or for treatment of wounds resulting from accidents and other types of injury or trauma.
    Type: Grant
    Filed: April 2, 2003
    Date of Patent: June 29, 2010
    Assignee: Venomics PTY Limited
    Inventors: Paul Pantaleone Masci, John De Jersey, Martin Lavin
  • Publication number: 20040043017
    Abstract: The invention relates to snake venom protease polypeptides and nucleic acid sequences encoding same. This invention also relates to methods of making and using the snake venom proteases, e.g., to promote haemostasis and prevent blood loss such as during surgery or for treatment of wounds resulting from accidents and other types of injury or trauma.
    Type: Application
    Filed: April 2, 2003
    Publication date: March 4, 2004
    Inventors: Paul Pantaleone Masci, John De Jersey, Martin Lavin